Tender detail
Open-house rebate agreements 2026-21: lisdexamfetamine (90 units)
Summary
The health insurers are seeking rebate agreements for lisdexamfetamine medicines in the 90-unit presentation. Under this open-house procedure, agreements use uniform terms, are non-exclusive and may generally run for up to 16 months, starting no earlier than 1 December 2026 and ending by 31 March 2028.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.